1. Home
  2. LXRX vs XYF Comparison

LXRX vs XYF Comparison

Compare LXRX & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • XYF
  • Stock Information
  • Founded
  • LXRX 1995
  • XYF 2014
  • Country
  • LXRX United States
  • XYF China
  • Employees
  • LXRX N/A
  • XYF N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • XYF Finance: Consumer Services
  • Sector
  • LXRX Health Care
  • XYF Finance
  • Exchange
  • LXRX Nasdaq
  • XYF Nasdaq
  • Market Cap
  • LXRX 352.5M
  • XYF 385.0M
  • IPO Year
  • LXRX 2000
  • XYF 2018
  • Fundamental
  • Price
  • LXRX $0.75
  • XYF $8.13
  • Analyst Decision
  • LXRX Buy
  • XYF
  • Analyst Count
  • LXRX 2
  • XYF 0
  • Target Price
  • LXRX $6.00
  • XYF N/A
  • AVG Volume (30 Days)
  • LXRX 4.9M
  • XYF 43.3K
  • Earning Date
  • LXRX 11-12-2024
  • XYF 11-26-2024
  • Dividend Yield
  • LXRX N/A
  • XYF 4.08%
  • EPS Growth
  • LXRX N/A
  • XYF 2.79
  • EPS
  • LXRX N/A
  • XYF 3.88
  • Revenue
  • LXRX $5,229,000.00
  • XYF $763,521,851.00
  • Revenue This Year
  • LXRX $886.38
  • XYF N/A
  • Revenue Next Year
  • LXRX $181.58
  • XYF N/A
  • P/E Ratio
  • LXRX N/A
  • XYF $2.16
  • Revenue Growth
  • LXRX 886.60
  • XYF 16.99
  • 52 Week Low
  • LXRX $0.62
  • XYF $3.48
  • 52 Week High
  • LXRX $3.73
  • XYF $8.59
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 36.22
  • XYF 66.02
  • Support Level
  • LXRX $0.62
  • XYF $7.64
  • Resistance Level
  • LXRX $0.85
  • XYF $8.49
  • Average True Range (ATR)
  • LXRX 0.09
  • XYF 0.47
  • MACD
  • LXRX 0.03
  • XYF 0.09
  • Stochastic Oscillator
  • LXRX 28.55
  • XYF 84.92

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, and guarantee services provided.

Share on Social Networks: